PHASE-I CONTROLLED TRIALS OF WR-2721 AND CYCLOPHOSPHAMIDE

被引：42
作者：
GLICK, JH
GLOVER, D
WEILER, C
NORFLEET, L
YUHAS, J
KLIGERMAN, MM
机构：
[1] UNIV PENN,CTR CANC,HEMATOL ONCOL SECT,PHILADELPHIA,PA 19104
[2] UNIV PENN,CTR CANC,DEPT RADIOTHERAPY,PHILADELPHIA,PA 19104
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1984年 / 10卷 / 09期
关键词：
D O I：
10.1016/0360-3016(84)90548-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1777 / 1780
页数：4
相关论文
共 10 条
  • [1] BERGSAGEL DE, 1968, CAN MED ASSOC J, V98, P532
  • [2] PHASE-I CLINICAL-TRIALS OF WR-2721 WITH ALKYLATING AGENT CHEMOTHERAPY
    GLICK, JH
    GLOVER, DJ
    WEILER, C
    BLUMBERG, A
    NELSON, D
    YUHAS, JM
    KLIGERMAN, M
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (3-4): : 575 - 580
  • [3] GLICK JH, 1983, 1ST P C RAD ANT, P719
  • [4] KLIGERMAN MM, 1981, CANCER CLIN TRIALS, V4, P469
  • [5] PHILLIPS TL, 1981, SEMIN ONCOL, V8, P65
  • [6] WASSERMAN TH, 1981, CANCER CLIN TRIALS, V4, P3
  • [7] CLINICAL-TRIAL OF THE EFFECT OF S-2-(3-AMINOPROPYLAMINO)-ETHYLPHOSPHOROTHIOIC ACID (WR-2721) (NSC-296961) ON THE TOXICITY OF CYCLOPHOSPHAMIDE
    WOOLLEY, PV
    AYOOB, MJ
    SMITH, FP
    DRITSCHILO, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (03) : 198 - 203
  • [8] TREATMENT OF TUMORS WITH THE COMBINATION OF WR-2721 AND CIS-DICHLORODIAMMINEPLATINUM (II) OR CYCLOPHOSPHAMIDE
    YUHAS, JM
    SPELLMAN, JM
    JORDAN, SW
    PARDINI, MC
    AFZAL, SMJ
    CULO, F
    [J]. BRITISH JOURNAL OF CANCER, 1980, 42 (04) : 574 - 585
  • [9] YUHAS JM, 1979, CANCER TREAT REP, V63, P971
  • [10] Yuhas JMS, 1980, RAD SENSITIZERS, P303
1